We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Circassia Group plc (CIR) Ordinary Shares 0.08p

Sell:35.60p Buy:36.00p 0 Change: 0.20p (0.56%)
Market closed Prices as at close on 27 May 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:35.60p
Buy:36.00p
Change: 0.20p (0.56%)
Market closed Prices as at close on 27 May 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:35.60p
Buy:36.00p
Change: 0.20p (0.56%)
Market closed Prices as at close on 27 May 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Circassia Group Plc is a United Kingdom-based medical device company, which is focused on point of care asthma diagnosis and management. The Company operates through two segments: NIOX and COPD. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). The COPD segment relates to the Tudorza and Duaklir Pressair products marketed in the United States, where they are indicated for the maintenance treatment of patients with COPD. Its NIOX FeNO measurement and monitoring products are used by physicians around the world to help improve asthma diagnosis and management. Its FeNO diagnosis and management products helps healthcare to professionals manage their patient's asthma. Its NIOX VERO is a non-invasive, point-of-care system that provides FeNO measurements. The Company provides products and services in around 50 countries.

Contact details

Address:
Northbrook House, Robert Robinson Avenue
OXFORD
OX4 4GA
United Kingdom
Telephone:
+44 (01865) 405560
Website:
www.circassia.com/

Important dates

Future events
There are no future events available.
Past events
AGM 12 May 2022 12/05/22
Annual report 13 April 2022 13/04/22
Final results 22 March 2022 22/03/22
Trading Announcement 13 January 2022 13/01/22
Interim results 16 September 2021 16/09/21
Trading Announcement 13 July 2021 13/07/21

General stock information

EPIC:
CIR
ISIN:
GB00BJVD3B28
Market cap:
£150.95 million
Shares in issue:
419.32 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Ian Johnson
    Executive Chairman of the Board
  • Michael Roller
    Chief Financial Officer, Executive Director
  • Jonathan Emms
    Chief Operating Officer, Executive Director
  • Sarah Duncan
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.